+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Endometriosis Drugs Market - Global Forecast 2026-2032- Product Image
Endometriosis Drugs Market - Global Forecast 2026-2032- Product Image
New

Endometriosis Drugs Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6015277
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The endometriosis drugs market is experiencing a dynamic shift as scientific innovation, regulatory realignment, and evolving patient needs reshape clinical development and commercialization strategies. Stakeholders need to align investment and operational planning with the latest market realities to achieve sustainable growth in this rapidly evolving therapeutic area.

Market Snapshot: Endometriosis Drugs Market Overview

The Endometriosis Drugs Market expanded from USD 2.89 billion in 2025 to USD 3.11 billion in 2026. It is expected to sustain robust growth at a CAGR of 7.49%, reaching USD 4.80 billion by 2032. Market momentum is driven by demand for novel symptom control, disease modification approaches, and the expansion of value-based care delivery models. Senior decision-makers are recalibrating sourcing, regulatory, and commercial strategies in response.

Scope & Segmentation

  • Drug Classes: Aromatase Inhibitors, GnRH Analogs (Long-Acting, Short-Acting), NSAIDs, Oral Contraceptives (Biphasic, Monophasic, Triphasic), and Progestins.
  • Distribution Channels: Hospital Pharmacies (Private, Public), Online Pharmacies (Direct-To-Consumer, Platform-Based), and Retail Pharmacies (Chain, Independent).
  • Product Types: Branded drugs and Generics are analyzed for differentiation and lifecycle pressures.
  • Routes of Administration: Injectable, Oral, and Topical formats impact adherence and infrastructure planning.
  • End Users: Hospitals, Clinics, and Home Healthcare providers, illustrating the shift toward decentralized, patient-centered pathways.
  • Mechanisms of Action: Hormonal Therapy and Pain Management, reflecting dual development priorities for symptom relief and disease modulation.
  • Regions Covered: Americas, Europe Middle East & Africa, and Asia-Pacific, each presenting unique access and regulatory trends.

Key Takeaways for Strategic Planning

  • Heightened clinical and diagnostic complexity is encouraging investment in novel therapeutics, including advanced hormonal modulators, alternative delivery systems, and complementary pain management solutions.
  • Broader acceptance of patient-centered endpoints and holistic health metrics is transforming both clinical trial design and reimbursement discussions, requiring integration of real-world evidence beyond registration studies.
  • Product differentiation now extends to digital health integration, personalized support services, and alignment with diagnostic innovations, strengthening competitive positioning beyond traditional drug attributes.
  • Sophisticated procurement models increasingly require cross-functional alignment, balancing efficacy, safety, adherence, and total cost to meet institutional goals.
  • Lifecycle management and R&D partnerships are critical for sustaining brand value, accelerating evidence generation, and accessing emerging delivery mechanisms and geographies.
  • Global supply disruptions and dynamic sourcing conditions highlight the value of resilient manufacturing and flexible channel strategies.

Tariff Impact on Sourcing and Pricing Strategies

Recent changes in United States tariff policies are redefining procurement and manufacturing operations for endometriosis therapeutics. Increased duties on certain ingredients and finished products are leading to recalibration of supplier networks, with a strong focus on nearshoring and dual sourcing to reduce risk. Commercial teams must adapt pricing and reimbursement approaches to prevent payer opposition or access barriers arising from cost pass-throughs. Localization of production and regional partnerships are emerging as mitigation strategies for margin and supply stability.

Methodology & Data Sources

This market analysis utilizes a mixed-methods approach, incorporating structured interviews with clinicians, payers, and commercial executives, as well as review of peer-reviewed literature and regulatory updates. Triangulation techniques validate insights across clinical practices, procurement policies, and commercial trends. Supply chain analysis was included to highlight operational risks. Methodological transparency ensures actionable and reproducible results.

Why This Report Matters

  • Supports executive planning with detailed insights on market growth drivers, regional nuances, and evolving therapeutic strategies.
  • Enables evidence-based decision making by integrating regulatory, clinical, and commercial data into a single, strategic reference.
  • Guides investment and partnership strategies to address unmet needs and navigate tariff, manufacturing, and channel complexities.

Conclusion

The future of endometriosis therapeutics will be determined by the ability to unify clinical innovation, regulatory engagement, and differentiated commercialization. This report delivers the market context and strategic insights needed for leaders to prioritize investments and secure lasting competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Endometriosis Drugs Market, by Drug Class
8.1. Aromatase Inhibitors
8.2. GnRH Analogs
8.2.1. Long-Acting
8.2.2. Short-Acting
8.3. NSAIDs
8.4. Oral Contraceptives
8.4.1. Biphasic
8.4.2. Monophasic
8.4.3. Triphasic
8.5. Progestins
9. Endometriosis Drugs Market, by Route Of Administration
9.1. Injectable
9.2. Oral
9.3. Topical
10. Endometriosis Drugs Market, by Mechanism Of Action
10.1. Hormonal Therapy
10.2. Pain Management
11. Endometriosis Drugs Market, by Product Type
11.1. Branded
11.2. Generic
12. Endometriosis Drugs Market, by Distribution Channel
12.1. Hospital Pharmacies
12.1.1. Private Hospital Pharmacies
12.1.2. Public Hospital Pharmacies
12.2. Online Pharmacies
12.2.1. Direct-To-Consumer Online Pharmacies
12.2.2. Platform-Based Online Pharmacies
12.3. Retail Pharmacies
12.3.1. Chain Retail Pharmacies
12.3.2. Independent Retail Pharmacies
13. Endometriosis Drugs Market, by End User
13.1. Clinics
13.2. Home Healthcare
13.3. Hospitals
14. Endometriosis Drugs Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Endometriosis Drugs Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Endometriosis Drugs Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Endometriosis Drugs Market
18. China Endometriosis Drugs Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. Bayer AG
19.7. Dr. Reddy’s Laboratories Limited
19.8. Ferring Pharmaceuticals
19.9. Ferring Pharmaceuticals Inc.
19.10. Myovant Sciences GmbH
19.11. Pfizer Inc.
19.12. Sandoz International GmbH
19.13. Sun Pharmaceutical Industries Limited
19.14. Takeda Pharmaceutical Company Limited
19.15. Teva Pharmaceutical Industries Ltd.
19.16. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ENDOMETRIOSIS DRUGS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ENDOMETRIOSIS DRUGS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY AROMATASE INHIBITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY AROMATASE INHIBITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY AROMATASE INHIBITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY LONG-ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY LONG-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY SHORT-ACTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY SHORT-ACTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY SHORT-ACTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY NSAIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY NSAIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY NSAIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BIPHASIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BIPHASIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BIPHASIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MONOPHASIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MONOPHASIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MONOPHASIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TRIPHASIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TRIPHASIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TRIPHASIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PROGESTINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PROGESTINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PROGESTINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TOPICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY TOPICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HORMONAL THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HORMONAL THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRIVATE HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PUBLIC HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DIRECT-TO-CONSUMER ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DIRECT-TO-CONSUMER ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY DIRECT-TO-CONSUMER ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PLATFORM-BASED ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PLATFORM-BASED ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY PLATFORM-BASED ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CHAIN RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CHAIN RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CHAIN RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INDEPENDENT RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INDEPENDENT RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY INDEPENDENT RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 112. AMERICAS ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 149. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 151. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 152. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 153. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 154. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 155. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 157. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 158. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 159. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 160. EUROPE ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 163. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 175. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 176. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 177. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 178. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 179. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 180. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 181. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 182. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 183. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 184. AFRICA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 200. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 201. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 202. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 203. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 204. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 205. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 206. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 207. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 208. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 209. ASEAN ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 210. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 212. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 213. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 214. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 215. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 216. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 217. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 218. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 219. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 220. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 221. GCC ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 222. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 224. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 225. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 226. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 227. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 228. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 229. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 235. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 236. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 237. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 238. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 239. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 240. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 241. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 242. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 243. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 244. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 245. BRICS ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 246. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 247. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 248. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 249. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 250. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 251. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 252. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 253. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 254. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 255. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 256. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 257. G7 ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 258. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 259. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 260. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 261. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 262. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 263. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 264. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 265. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 266. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 267. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 268. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 269. NATO ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. GLOBAL ENDOMETRIOSIS DRUGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 271. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 272. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 273. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 274. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 275. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 276. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 277. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 278. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 279. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 280. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 281. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 282. UNITED STATES ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 283. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2032 (USD MILLION)
TABLE 285. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY GNRH ANALOGS, 2018-2032 (USD MILLION)
TABLE 286. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ORAL CONTRACEPTIVES, 2018-2032 (USD MILLION)
TABLE 287. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 288. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY MECHANISM OF ACTION, 2018-2032 (USD MILLION)
TABLE 289. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 290. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 291. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 292. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 293. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 294. CHINA ENDOMETRIOSIS DRUGS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

  • AbbVie Inc.
  • Bayer AG
  • Dr. Reddy’s Laboratories Limited
  • Ferring Pharmaceuticals
  • Ferring Pharmaceuticals Inc.
  • Myovant Sciences GmbH
  • Pfizer Inc.
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.11 Billion
Forecasted Market Value ( USD ) by 2032 $ 4.8 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

Endometriosis Treatment Market - Global Forecast 2026-2032 - Product Image

Endometriosis Treatment Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Endometriosis Market Report and Forecast 2025-2034 - Product Image

Endometriosis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Endometriosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Endometriosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
Endometriosis Market Report 2025 - Product Image

Endometriosis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Endometriosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Endometriosis Treatment Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 107 Pages
  • Global
From

About the Endometriosis Drug Market

The Endometriosis Drug market is a subset of the Immune Disorders Drugs market. Endometriosis is a condition in which the tissue that normally lines the uterus grows outside of the uterus, causing pain and other symptoms. Endometriosis drugs are used to treat the symptoms of endometriosis, such as pain, heavy menstrual bleeding, and infertility. These drugs can be divided into two categories: hormonal therapies and non-hormonal therapies. Hormonal therapies include oral contraceptives, progestins, and gonadotropin-releasing hormone agonists. Non-hormonal therapies include non-steroidal anti-inflammatory drugs, danazol, and GnRH antagonists. Some companies in the Endometriosis Drug market include AbbVie, Allergan, Bayer, Merck, and Pfizer. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.